Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-25-000130

Chief Operations Officer acquired 7,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
English Emily Chief Operations Officer 2025-11-28 Option exercise +7,500 $3.30 $24,750 62,726 D
Derivatives
English Emily Chief Operations Officer 2025-11-28 Option exercise · Stock Option (Right to Buy) −7,500 26,869 D
Loading xslF345X05/wk-form4_1764709364.xml…